TMC News reports on the investigational peptide drug TP508, which combats the effects of nuclear radiation and increases the chances of survival after exposure. This drug works by preventing damage to the GI tract, as the level of radiation-induced damage to the intestines is an indicator of whether someone will survive after total body exposure.